Bitopertin
disc
[]
disc presents positive initial data from phase 2 beacon trial of bitopertin in patients with erythropoietic protoporphyria (epp) at european hematology association (eha) 2023 congress #stocksoftheday #stockalert #stocknews #phase2 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!